annual cash & cash equivalents:
$1.38B-$831.97M(-37.69%)Summary
- As of today (May 20, 2025), GMAB annual cash & cash equivalents is $1.38 billion, with the most recent change of -$831.97 million (-37.69%) on December 31, 2024.
- During the last 3 years, GMAB annual cash & cash equivalents has risen by +$11.78 million (+0.86%).
- GMAB annual cash & cash equivalents is now -37.69% below its all-time high of $2.21 billion, reached on December 31, 2023.
Performance
GMAB Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.62B+$243.64M(+17.71%)Summary
- As of today (May 20, 2025), GMAB quarterly cash & cash equivalents is $1.62 billion, with the most recent change of +$243.64 million (+17.71%) on March 1, 2025.
- Over the past year, GMAB quarterly cash & cash equivalents has dropped by -$503.09 million (-23.71%).
- GMAB quarterly cash & cash equivalents is now -26.65% below its all-time high of $2.21 billion, reached on December 31, 2023.
Performance
GMAB quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GMAB Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.7% | -23.7% |
| 3 y3 years | +0.9% | +18.9% |
| 5 y5 years | +158.3% | +97.8% |
GMAB Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.7% | +0.9% | -26.6% | +160.4% |
| 5 y | 5-year | -37.7% | +158.3% | -26.6% | +160.4% |
| alltime | all time | -37.7% | >+9999.0% | -26.6% | >+9999.0% |
GMAB Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.62B(+17.7%) |
| Dec 2024 | $1.38B(-37.7%) | $1.38B(+44.8%) |
| Sep 2024 | - | $949.92M(+52.8%) |
| Jun 2024 | - | $621.73M(-70.7%) |
| Mar 2024 | - | $2.12B(-3.9%) |
| Dec 2023 | $2.21B(+55.0%) | $2.21B(+9.2%) |
| Sep 2023 | - | $2.02B(+27.4%) |
| Jun 2023 | - | $1.59B(-11.8%) |
| Mar 2023 | - | $1.80B(+26.3%) |
| Dec 2022 | $1.42B(+4.4%) | $1.42B(+3.8%) |
| Sep 2022 | - | $1.37B(-0.5%) |
| Jun 2022 | - | $1.38B(+1.2%) |
| Mar 2022 | - | $1.36B(-0.2%) |
| Dec 2021 | $1.36B(+13.6%) | $1.36B(+0.1%) |
| Sep 2021 | - | $1.36B(-10.2%) |
| Jun 2021 | - | $1.52B(+21.9%) |
| Mar 2021 | - | $1.24B(+3.7%) |
| Dec 2020 | $1.20B(+125.3%) | $1.20B(-14.4%) |
| Sep 2020 | - | $1.40B(+40.7%) |
| Jun 2020 | - | $996.39M(+21.7%) |
| Mar 2020 | - | $818.63M(+53.7%) |
| Dec 2019 | $532.52M(+552.2%) | $532.52M(-21.7%) |
| Sep 2019 | - | $680.39M(+666.2%) |
| Jun 2019 | - | $88.80M(-49.8%) |
| Mar 2019 | - | $176.85M(+116.6%) |
| Dec 2018 | $81.65M(-62.4%) | $81.65M(-41.4%) |
| Sep 2018 | - | $139.42M(-17.3%) |
| Jun 2018 | - | $168.64M(+6.6%) |
| Mar 2018 | - | $158.17M(-27.2%) |
| Dec 2017 | $217.16M(+397.4%) | $217.16M(+26.3%) |
| Sep 2017 | - | $171.97M(+8.4%) |
| Jun 2017 | - | $158.71M(+44.5%) |
| Mar 2017 | - | $109.81M(+152.8%) |
| Dec 2016 | $43.66M | $43.44M(-63.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $119.90M(+25.0%) |
| Jun 2016 | - | $95.95M(-0.6%) |
| Mar 2016 | - | $96.53M(-24.6%) |
| Dec 2015 | $128.02M(+118.4%) | $128.02M(+45.3%) |
| Sep 2015 | - | $88.13M(+59.7%) |
| Jun 2015 | - | $55.20M(+15.9%) |
| Mar 2015 | - | $47.63M(-18.8%) |
| Dec 2014 | $58.63M(+88.4%) | $58.63M(+26.5%) |
| Sep 2014 | - | $46.33M(-35.6%) |
| Jun 2014 | - | $71.97M(-41.7%) |
| Mar 2014 | - | $123.49M(+296.8%) |
| Dec 2013 | $31.12M(+162.1%) | $31.12M(-5.2%) |
| Sep 2013 | - | $32.81M(+3.0%) |
| Jun 2013 | - | $31.84M(+46.5%) |
| Mar 2013 | - | $21.74M(+83.1%) |
| Dec 2012 | $11.87M(+4.5%) | $11.87M(-83.2%) |
| Sep 2012 | - | $70.61M(+227.0%) |
| Jun 2012 | - | $21.59M(+7.3%) |
| Mar 2012 | - | $20.13M(+76.9%) |
| Dec 2011 | $11.36M(-36.9%) | $11.38M(-62.2%) |
| Sep 2011 | - | $30.11M(+67.7%) |
| Jun 2011 | - | $17.96M(-6.4%) |
| Mar 2011 | - | $19.19M(+6.6%) |
| Dec 2010 | $18.01M(-79.7%) | $18.01M(-76.2%) |
| Sep 2010 | - | $75.80M(+6.4%) |
| Jun 2010 | - | $71.21M(+47.3%) |
| Mar 2010 | - | $48.34M(-45.5%) |
| Dec 2009 | $88.62M(+574.5%) | $88.71M |
| Dec 2008 | $13.14M(-49.0%) | - |
| Dec 2007 | $25.77M(-66.0%) | - |
| Dec 2006 | $75.89M(+25.5%) | - |
| Dec 2005 | $60.49M(-20.8%) | - |
| Dec 2004 | $76.38M(+46.2%) | - |
| Dec 2003 | $52.25M(+46.3%) | - |
| Dec 2002 | $35.71M | - |
FAQ
- What is Genmab A/S annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Genmab A/S?
- What is Genmab A/S annual cash & cash equivalents year-on-year change?
- What is Genmab A/S quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Genmab A/S?
- What is Genmab A/S quarterly cash & cash equivalents year-on-year change?
What is Genmab A/S annual cash & cash equivalents?
The current annual cash & cash equivalents of GMAB is $1.38B
What is the all time high annual cash & cash equivalents for Genmab A/S?
Genmab A/S all-time high annual cash & cash equivalents is $2.21B
What is Genmab A/S annual cash & cash equivalents year-on-year change?
Over the past year, GMAB annual cash & cash equivalents has changed by -$831.97M (-37.69%)
What is Genmab A/S quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GMAB is $1.62B
What is the all time high quarterly cash & cash equivalents for Genmab A/S?
Genmab A/S all-time high quarterly cash & cash equivalents is $2.21B
What is Genmab A/S quarterly cash & cash equivalents year-on-year change?
Over the past year, GMAB quarterly cash & cash equivalents has changed by -$503.09M (-23.71%)